PI
ALNY icon

PEAK6 Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

PEAK6 Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$163K Sell
591
-2,087
-78% -$543K ﹤0.01% 2858
2024
Q2 		$651K Sell
2,678
-5,519
-67% -$871K ﹤0.01% 2095
2024
Q1 		$1.23M Buy
8,197
+3,338
+69% +$557K ﹤0.01% 1792
2023
Q4 		$930K Sell
4,859
-8,253
-63% -$1.41M ﹤0.01% 2147
2023
Q3 		$2.32M Buy
13,112
+4,743
+57% +$905K 0.01% 1230
2023
Q2 		$1.59M Buy
8,369
+1,591
+23% +$315K 0.01% 1357
2023
Q1 		$1.36M Buy
6,778
+3,465
+105% +$728K 0.01% 1610
2022
Q4 		$787K Sell
3,313
-2,431
-42% -$519K ﹤0.01% 2127
2022
Q3 		$1.15M Sell
5,744
-2,625
-31% -$501K ﹤0.01% 2062
2022
Q2 		$1.59M Buy
+8,369
New +$1.19M 0.01% 1358
2022
Q1 		– Sell
-4,704
Closed -$717K – 5120
2021
Q4 		$798K Buy
+4,704
New +$874K ﹤0.01% 2762
2021
Q3 		– Sell
-14,820
Closed -$2.51M – 5082
2021
Q2 		$2.51M Buy
+14,820
New +$2.17M 0.01% 1663
2021
Q1 		– Sell
-29,571
Closed -$4.45M – 4789
2020
Q4 		$3.84M Buy
29,571
+17,438
+144% +$2.33M 0.01% 1282
2020
Q3 		$1.77M Sell
12,133
-20,396
-63% -$2.9M ﹤0.01% 1777
2020
Q2 		$4.82M Sell
32,529
-5,181
-14% -$698K 0.02% 845
2020
Q1 		$4.11M Buy
37,710
+36,056
+2,180% +$4.16M 0.02% 610
2019
Q4 		$190K Sell
1,654
-24,577
-94% -$2.45M ﹤0.01% 2573
2019
Q3 		$2.11M Buy
26,231
+20,861
+388% +$1.65M 0.01% 1239
2019
Q2 		$390K Buy
+5,370
New +$412K ﹤0.01% 2442

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PEAK6 Investments's ALNY Position: Q3 2024 in Review

PEAK6 Investments reduced its Alnylam Pharmaceuticals (ALNY) stake by 78% in Q3 2024, selling an estimated $543K and leaving 591 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

PEAK6 Investments first reported a position in ALNY in Q2 2019 and has held it in 19 quarters since. The position peaked at $4.82M in Q2 2020. 567 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • PEAK6 Investments held 591 shares of Alnylam Pharmaceuticals worth $163K as of Q3 2024.
  • PEAK6 Investments sold 2,087 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $543K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2858 holding.
  • PEAK6 Investments first reported a position in Alnylam Pharmaceuticals in Q2 2019 and has held it in 19 quarters since.
  • PEAK6 Investments's Alnylam Pharmaceuticals position peaked at $4.82M in Q2 2020.
  • 567 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.